Advanced-stage CHL with low IPS was found to have significantly lower CTLA-4 expression than the high IPS group (210.1 ± 52.4 cells/FOV vs. 303.3 ± 113.5 cells/FOV). This evidence concerns the gene CTLA4 and classic Hodgkin lymphoma.